Trump admin strikes zero tariff pharmaceutical deal with Britain — a move welcomed by drugmakers

The United States and Britain announced a deal on Monday to secure zero tariffs on British pharmaceutical products and medical technology in return for Britain spending more on medicines and overhauling how it values drugs. Under the agreement, Britain will raise the net price it pays for new US medicines by 25%. In return, UK-made medicines, drug ingredients and medical technology will be exempt...